CD151 expression can predict cancer progression in clear cell renal cell carcinoma

Histopathology

Volumn 58, Issue 2, 2011, Pages 191-197

  Yoo, Seong H ^a   Lee, Kyoungbun ^a   Chae, Ji Y ^a   Moon, Kyung C ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

CD151; Clear cell renal cell carcinoma; Prognosis; Progression

Indexed keywords

CD151 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79951636263     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03752.x     Document Type: Article

References (31)

1. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183; 131-133.
2. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr. Opin. Urol. 2007; 17; 303-308.
3. Jung EJ, Lee HJ, Kwak C, Ku JH, Moon KC. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Urology 2009; 73; 137-141.
4. Leibovich BC, Blute ML, Cheville JC et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97; 1663-1671.
5. Kim HL, Seligson D, Liu X et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 2004; 10; 5464-5471.
6. Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr. Urol. Rep. 2005; 6; 7-18.
7. Tamaskar I, Pili R. Update on novel agents in renal cell carcinoma. Exp. Rev. Anticancer Ther. 2009; 9; 1817-1827.
8. Hasegawa H, Utsunomiya Y, Kishimoto K, Yanagisawa K, Fujita S. SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily. J. Virol. 1996; 70; 3258-3263.
9. Chattopadhyay N, Wang Z, Ashman LK, Brady-Kalnay SM, Kreidberg JA. alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J. Cell Biol. 2003; 163; 1351-1362.
10. Zhang XA, Kazarov AR, Yang X, Bontrager AL, Stipp CS, Hemler ME. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol. Biol. Cell 2002; 13; 1-11.
11. Takeda Y, Kazarov AR, Butterfield CE et al. Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007; 109; 1524-1532.
12. Testa JE, Brooks PC, Lin JM, Quigley JP. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. 1999; 59; 3812-3820.
13. Yang XH, Richardson AL, Torres-Arzayus MI et al. CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res. 2008; 68; 3204-3213.
14. Hashida H, Takabayashi A, Tokuhara T et al. Clinical significance of transmembrane 4 superfamily in colon cancer. Br. J. Cancer 2003; 89; 158-167.
15. Ke AW, Shi GM, Zhou J et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 2009; 49; 491-503.
16. Tokuhara T, Hasegawa H, Hattori N et al. Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin. Cancer Res. 2001; 7; 4109-4114.
17. Gesierich S, Paret C, Hildebrand D et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin. Cancer Res. 2005; 11; 2840-2852.
18. Ang J, Lijovic M, Ashman LK, Kan K, Frauman AG. CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator? Cancer Epidemiol. Biomarkers Prev. 2004; 13; 1717-1721.
19. Chien CW, Lin SC, Lai YY, Lin BW, Lee JC, Tsai SJ. Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer. Clin. Cancer Res. 2008; 14; 8043-8051.
20. Sobin L, Wittekind C. TNM classification of malignant tumors. New York, NY: Wiley-Liss, 2002.
21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982; 6; 655-663.
22. Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 2003; 19; 397-422.
23. Berditchevski F, Gilbert E, Griffiths MR, Fitter S, Ashman L, Jenner SJ. Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis. J. Biol. Chem. 2001; 276; 41165-41174.
24. Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A. The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J. Cell Biol. 2000; 149; 969-982.
25. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 2009; 9; 40-55.
26. Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, Lee H. Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J. Biol. Chem. 2006; 281; 24279-24292.
27. Shiomi T, Inoki I, Kataoka F et al. Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab. Invest. 2005; 85; 1489-1506.
28. Kohno M, Hasegawa H, Miyake M, Yamamoto T, Fujita S. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int. J. Cancer 2002; 97; 336-343.
29. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008; 13; 221-234.
30. Sadej R, Romanska H, Baldwin G et al. CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol. Cancer Res. 2009; 7; 787-798.
31. Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H, Hamakawa H. CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem. Biophys. Res. Commun. 2005; 336; 408-416.